HeartBeam, Inc. (BEAT)
| Market Cap | 36.78M -32.0% |
| Revenue (ttm) | n/a |
| Net Income | -20.23M |
| EPS | -0.56 |
| Shares Out | 55.51M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 588,633 |
| Open | 0.6495 |
| Previous Close | 0.6400 |
| Day's Range | 0.6342 - 0.6869 |
| 52-Week Range | 0.5400 - 4.0000 |
| Beta | -0.87 |
| Analysts | Strong Buy |
| Price Target | 3.83 (+477.94%) |
| Earnings Date | Aug 12, 2026 |
About BEAT
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart’s electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician port... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for BEAT stock is "Strong Buy." The 12-month stock price target is $3.83, which is an increase of 477.94% from the latest price.
News
HeartBeam Proxy statement: Proxy filing
HeartBeam filed a proxy statement on June 25, 2026, providing details for shareholder voting and corporate governance matters.
HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition.
HeartBeam Proxy statement: Proxy filing
HeartBeam filed a proxy statement on June 18, 2026, providing details for shareholder voting and corporate governance matters.
HeartBeam Proxy statement: Proxy filing
HeartBeam filed a proxy statement on June 5, 2026, providing details for shareholder voting and corporate governance matters.
HeartBeam Slides: Investor presentation
HeartBeam has posted slides in relation to its latest quarterly earnings report, which was published on June 5, 2026.
HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home.
HeartBeam Earnings Call Transcript: Q1 2026
Achieved key milestones in commercialization, clinical validation, and product development, including flagship accounts in four major geographies and a strategic AI partnership. Q1 2026 saw a 19% year-over-year reduction in cash burn, with a strengthened balance sheet and funding runway into 2027.
HeartBeam Quarterly report: Q1 2026
HeartBeam has published its Q1 2026 quarterly earnings report on May 13, 2026.
HeartBeam Slides: Q1 2026
HeartBeam has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 13, 2026.
HeartBeam Earnings release: Q1 2026
HeartBeam released its Q1 2026 earnings on May 13, 2026, summarizing the period's financial results.
HeartBeam Reports First Quarter 2026 Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports First Quarter 2026 Results.
HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic.
HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice.
HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time.
HeartBeam Announces Closing of $10 Million Public Offering of Common Stock
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Closing of $10 Million Public Offering of Common Stock.
HeartBeam Slides: Investor presentation
HeartBeam has posted slides in relation to its latest quarterly earnings report, which was published on April 16, 2026.
HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock.
HeartBeam Announces Proposed Public Offering of Common Stock
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Proposed Public Offering of Common Stock.
HeartBeam Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference
A novel at-home 12-lead ECG platform is launching with a subscription model targeting concierge cardiology, leveraging strong physician and patient demand. The company is expanding into ambulatory monitoring and AI-driven cardiac care, supported by clinical studies and strategic partnerships.
HeartBeam Registration statement: Registration Filing
HeartBeam filed a registration statement on March 13, 2026, providing details about a securities offering with the SEC.
HeartBeam Earnings Call Transcript: Q4 2025
FDA clearance for 12-lead ECG software enabled commercial launch and partnerships, with strong demand in concierge cardiology. Net loss narrowed, cash use declined, and 2026 will focus on scaling adoption, clinical studies, and AI development.
HeartBeam Earnings release: Q4 2025
HeartBeam released its Q4 2025 earnings on March 12, 2026, summarizing the period's financial results.
HeartBeam Annual report: Q4 2025
HeartBeam has published its Q4 2025 annual report on March 12, 2026.
HeartBeam Slides: Q4 2025
HeartBeam has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 12, 2026.
HeartBeam Reports Fourth Quarter and Full Year 2025 Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Fourth Quarter and Full Year 2025 Results.